NCT01792037 is a Phase 4 clinical trial of Etomidate in Adrenocortical Deficiency, sponsored by Istanbul University.

Who is sponsoring NCT01792037?

NCT01792037 is sponsored by Istanbul University.

What drugs are being tested in NCT01792037?

Interventions in NCT01792037: Etomidate, Midazolam, methylprednisolone.

What condition does NCT01792037 study?

NCT01792037 studies Adrenocortical Deficiency, Hemodynamic Instability.

Is NCT01792037 still recruiting?

NCT01792037 is currently completed. Last updated 23 August 2013.

Last reviewed 2013-08-23 · How we verify

NCT01792037

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Effect of Single Dose of Etomidate Used During Emergency Intubation on Hemodynamics and Adrenal Cortex: a Randomized Clinical Trial

Completed Phase 4 Last updated 23 August 2013

What this trial tests

Phase 4 trial testing Etomidate in Adrenocortical Deficiency in 90 participants. Completed in 1 March 2013.

Timeline

1 December 2012

Primary endpoint
1 March 2013

1 March 2013

Quick facts

Lead sponsor	Istanbul University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	prevention
Enrollment	90
Start date	1 December 2012
Primary completion	1 March 2013
Estimated completion	1 March 2013
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Etomidate (ETOMIDATE) — full drug profile →
Midazolam (midazolam) — full drug profile →
methylprednisolone (methylprednisolone) — full drug profile →

Conditions studied

Adrenocortical Deficiency — all drugs for Adrenocortical Deficiency →
Hemodynamic Instability — all drugs for Hemodynamic Instability →

Sponsor

Istanbul University

Who can join

Adults 25 to 65, any sex, with Adrenocortical Deficiency or Hemodynamic Instability. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

effect of use of steroid on adrenal cortex prior to single dose etomidate by comparing cortisol levels
Time frame: 24 hours

Sponsor's own description

we aim to evaluate the effects of single dose of etomidate or use of steroid prior to etomidate during emergency intubation on hemodynamics and adrenal cortex.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Etomidate

Trials testing the same drug.

NCT04291521 — Prospective Study of Induction Medications Used in the Trauma RSI · not yet recruiting
NCT07012902 — Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia · EARLY_PHASE1 · not yet recruiting
NCT06664138 — Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment · Phase 4 · completed
NCT05277896 — Randomized Trial of Sedative Choice for Intubation · Phase 4 · completed
NCT04934410 — Induction Agent and Incidence of Hypotension in Heart Failure Patients Undergoing LVAD-Implantation · unknown

Other Istanbul University trials

Trials by the same sponsor.

NCT07472946 — Whole-Body Vibration Exercise in Patients With Parkinson's Disease · NA · not yet recruiting
NCT07433894 — Scoliosis and Functional Outcomes in Children With Juvenile Idiopathic Arthritis · not yet recruiting
NCT07420049 — Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study · not yet recruiting
NCT07415967 — The Effect of a Dual-Task Technique-Based Exercise Program on Clinical Outcomes in Rotator Cuff Related Shoulder Pain · NA · recruiting
NCT07473024 — pEEG-Guided Anesthesia and Behavioral Outcomes in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01792037 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul University
Last refreshed: 23 August 2013

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01792037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing